Hemolysis-Associated Pulmonary Hypertension in Sickle Cell Disease: Global Disruption of the Arginine-Nitric Oxide Pathway

Publisher： Bentham Science Publishers

E-ISSN： 1875-6506|3|3|223-230

ISSN： 1573-4021

Source： Current Hypertension Reviews, Vol.3, Iss.3, 2007-08, pp. : 223-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pulmonary Hypertension Associated with Sickle Cell Disease: Pathophysiology and Rationale for Treatment

By Benza Raymond  

Lung, Vol. 186, Iss. 4, 2008-08 ,pp. : 247-254

Springer Publishing Company

Access to resources Recommend Favorite

New Strategies for the Treatment of Pulmonary Hypertension in Sickle Cell Disease: The Rationale for Arginine Therapy

By Morris Claudia R.  

Treatments in Respiratory Medicine, Vol. 5, Iss. 1, 2006-01 ,pp. : 31-45

Adis International

Access to resources Recommend Favorite

Molecular Link between Intravascular Hemolysis and Vascular Occlusion in Sickle Cell Disease

By  

Current Vascular Pharmacology, Vol. 10, Iss. 6, 2012-11 ,pp. : 756-761

Bentham Science Publishers

Access to resources Recommend Favorite

The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting

By Qi Jianguang   Du Junbao   Tang Xiuying   Li Jian   Wei Bing   Tang Chaoshu  

Heart and Vessels, Vol. 19, Iss. 2, 2004-03 ,pp. : 81-88

Springer Publishing Company

Access to resources Recommend Favorite

High Prevalence of Pulmonary Hypertension in Homozygous Sickle Cell Patients with Leg Ulceration

By Serarslan Gamze   Akgul Ferit   Babayigit Cenk  

Clinical and Experimental Hypertension, Vol. 31, Iss. 1, 2009-02 ,pp. : 44-48

Informa Healthcare

Access to resources Recommend Favorite